MedPath

Pharyngeal Electrical Stimulation in Amyotrophic Lateral Sclerosis

Phase 1
Completed
Conditions
Amyotrophic Lateral Sclerosis
Interventions
Device: Pharyngeal Electrical Stimulation
Registration Number
NCT03481348
Lead Sponsor
University of Ulm
Brief Summary

During the course of ALS most patients develop swallowing deficits. In this pilot study we investigate if dysphagia in ALS can be improved by Pharyngeal Electrical Stimulation (PES). PES is Communauté Européenne (CE-) certificated and has been approved for treatment of neurological, oropharyngeal dysphagia. During PES, electrical stimuli are applied at the pharynx via a nasogastral tube with the aim of triggering reorganization processes in damaged brain structures. There is evidence of a positive effect of PES in Stroke and Multiple Sclerosis patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • possible, probable or definite ALS according to the revised El Escorial criteria (Brooks et al. 2000)
  • age >18 years
  • able to understand all information and to give full consent according to good clinical practice (GCP)
  • moderate ot severe dysphagia, defined by a mean value (all consistencies) of 4
Exclusion Criteria
  • concurrent participation in another interventional trial
  • tracheostomy
  • severe psychiatric disorder or clinically manifest dementia
  • pulmonal or cardial disorder which constitutes a risk when inserting the tube into the pharynx
  • permanent cardiac pacemaker or defibrillator

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Pharyngeal Electrical StimulationPharyngeal Electrical StimulationPES for 10 minutes per day on 3 consecutive days in addition to standard therapy (logopedic counselling, advice for nutrition, learning of swallowing techniques)
Primary Outcome Measures
NameTimeMethod
Penetration Aspiration Scale (PAS) Scoreday 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90

Degree of Penetration and Aspiration evaluated by fiberendoscopic evaluation of swallowing (FEES)

Secondary Outcome Measures
NameTimeMethod
Swallowing-Quality of Life Score (SWAL-QOL)day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90

swallowing-specific quality of life questionnaire

Schluckbeeinträchtigungs-Skala (SBS) Scoreday 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90

Clinical scale to evaluate severity of dysphagia

Functional Oral Intake Scale (FOIS) Scoreday 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90

Clinical scale to evaluate the impairment of oral food intake

Dysphagia Severity Rating Scale (DSRS) Scoreday 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90

Clinical scale to evaluate severity of dysphagia

Amyotrophic Lateral Sclerosis Functional Rating Scale Revised (ALS-FRS-R)day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90

Clinical scale to evaluate the severity of symptoms in ALS

Frequency of Adverse Eventsday 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90

Frequency of Adverse Events

Trial Locations

Locations (1)

University of Ulm

🇩🇪

Ulm, Germany

© Copyright 2025. All Rights Reserved by MedPath